USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Anticoagulants Market By Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others), and By Application (Stroke, Atrial Fibrillation, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), and Others) : Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026

Covid-19

Global Anticoagulants Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[185+ Pages PDF Report] Global Anticoagulants market was approximately USD 27 Billion in 2019 and is anticipated to reach over USD 44 billion by 2026, at a CAGR of 7.8% during the forecast period.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Anticoagulants industry. The report analyzes and declares the historical and current trends analysis of the Anticoagulants industry and subsequently recommends the projected trends anticipated to be observed in the Anticoagulants market during the upcoming years.

The Anticoagulants market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Anticoagulants market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Anticoagulants industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Anticoagulants industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Anticoagulants market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Anticoagulants industry. The Anticoagulants market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Anticoagulants sector. Key strategic developments in the Anticoagulants market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Anticoagulants market are appropriately highlighted in the report.

The Anticoagulants market research report delivers an acute valuation and taxonomy of the Anticoagulants industry by practically splitting the market on the basis of different types, categories, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Anticoagulants industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the Anticoagulants industry is provided for the leading economies of the world.

Increased occurrences of chronic and cardiovascular disease, increased acceptance of novel oral anticoagulants (NOACs) and increased knowledge of the use of NOACs, increased population aging, lack of specific anticoagulant alternatives, advantageous government policies and an increasing number of obese individuals are key drivers of this problem. Increased investment by leading market players in developing new products and providing solutions to meet high patient needs would provide new opportunities for market players in the anticoagulant industry to develop new products. However, the high cost of NOACs, the existence of alternative medicines, strict government control, the risk of side effects, and complications in oral anticoagulants may limit global demand for anticoagulants.

The anticoagulant market is segmented based on drug type and region. On the basis of drug type segmentation, the market is classified into antidepressant drugs, mood stabilizers, antipsychotics drugs, and others.

logoTop Market Players

Some of the essential players operating in the Anticoagulants market, but not restricted to include Glaxo SmithKline (GSK), Eli Lilly, AstraZeneca, Pfizer Inc., Janssen Pharmaceuticals, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company Allergan Plc., Otsuka Holdings Co. Ltd., and Others.

logoThe taxonomy of the Anticoagulants Market by its scope and segmentation is as follows:

logo By Drug Class Segmentation Analysis

  • NOACs
  • Heparin & LMWH
  • Vitamin K Antagonist
  • Others

logo By Application Segmentation Analysis

  • Stroke
  • Atrial Fibrillation
  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Others

logo Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Covid-19

Anticoagulants Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

logoKey Insights from Primary Research

  • According to the primary CXO’s of the global Anticoagulants market, the market is estimated to witness a substantial growth of nearly 7.8% over the forecast period.
  • The market was valued at USD 27 billion, in 2019 and is expected to be valued over USD 44 billion.
  • On the basis of the drug class segment, NOACs dominated the global Anticoagulants market in 2019. In terms of revenue, it accounted for more than a 38% share of the total market in 2019.
  • Asia Pacific market is expected to be the fastest goring region for Anticoagulants over the forecast period owing to growing investments for R&D and pharmaceutical companies in the region.
  • By geography, the North America region headed the market with a share of above 31%, in 2019.

logoKey Recommendations from Analysts

  • Higher prevalence of chronic disorder, technological advances, high unmet medical needs, and government initiatives are major factors that are expected to drive the development of the treatment market for chronic and cardiovascular disorders in the near future.
  • The strategic developments such as regional expansion, product innovations, and on-going research and developments by the major companies such as Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH Portola Pharmaceuticals Inc., etc. is likely to boom the market’s growth over the upcoming years.
  • Our analysts recommend that the Asia Pacific region is predicted to witness significant growth attributed to the growing demand for Anticoagulants from China and India.
  • Expansion of pharmaceuticals companies especially in the emerging market is anticipated to fuel the demand for Anticoagulants drug in the developing regions over the forthcoming years.
  • Strengthening the distribution channel and growing availability of bipolar disorder drugs online may also help the major player to cater to the lucrative growth of the market over the years to come.

Covid-19

Anticoagulants Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Glaxo SmithKline (GSK)
  • Eli Lilly
  • AstraZeneca
  • Pfizer Inc.
  • Janssen Pharmaceuticals
  • AbbVie Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company Allergan Plc.
  • Otsuka Holdings Co. Ltd.

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Anticoagulants Market.
According to Facts and Factors research report, the global Anticoagulants Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Anticoagulants Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Anticoagulants Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Anticoagulants Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Drug Delivery in Cancer Market Report 2022–2028

[205+ Pages Report] According to Facts and Factors, the global drug delivery in cancer market was valued at USD 1527.40 million in 2021 and is predicted to increase at a CAGR of 6.70 % to USD 2253.92 million by 2028. The study examines the market in terms of revenue in each of the major regions, w...

Published Date : 13-Jun-2022 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample
report img

Breast Biopsy Market Report 2022 – 2028

[227+ Pages Report] According to Facts and Factors, the Global Breast Biopsy Market was valued at USD 702.13 million in 2021 and is predicted to increase at a CAGR of 7.3% to USD 1,109.35 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are cla...

Published Date : 03-Jun-2022 | | Category : | Pages : 227 | Format : Read more

Inquiry for Buying Request Sample